Covid-19 Impact on Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size, Status and Forecast 2020-2026

July 2020 | 132 pages | ID: CCC2C98C3E64EN
QYResearch

Abstracts

This report focuses on the global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing development in North America, Europe, China and Japan.
The key players covered in this study

• BioReliance
• Cobra Biologics
• Oxford BioMedica
• UniQure
• FinVector
• MolMed
• MassBiologics
• Richter-Helm
• FUJIFILM Diosynth Biotechnologies
• Lonza
• Aldevron
• Eurogentec
• Cell and Gene Therapy Catapult
• Biovian
• Brammer Bio
• VGXI
• PlasmidFactory
• bluebird bio
• Novasep
• Spark Therapeutics
• Vigene Biosciences

Market segment by Type, the product can be split into

• AAV
• Adenoviral
• Lentiviral
• Retroviral
• Plasmid DNA
• Other Vectors

Market segment by Application, split into

• Cancers
• Inherited Disorders
• Viral Infections
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing status, future forecast, growth opportunity, key market and key players.
• To present the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 AAV
  1.4.3 Adenoviral
  1.4.4 Lentiviral
  1.4.5 Retroviral
  1.4.6 Plasmid DNA
  1.4.7 Other Vectors
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2020 VS 2026
  1.5.2 Cancers
  1.5.3 Inherited Disorders
  1.5.4 Viral Infections
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industry Impact
  1.6.1 How the Covid-19 is Affecting the Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Industry
    1.6.1.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Growth Trends by Regions
  2.2.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Share by Regions (2015-2020)
  2.2.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Strategy
  2.3.6 Primary Interviews with Key Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Market Size
  3.1.1 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Revenue (2015-2020)
  3.1.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio
  3.2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2019
3.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2015-2020)
6.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2015-2020)
7.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020)

8 CHINA

8.1 China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2015-2020)
8.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2015-2020)
9.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020)

10KEY PLAYERS PROFILES

10.1 BioReliance
  10.1.1 BioReliance Company Details
  10.1.2 BioReliance Business Overview and Its Total Revenue
  10.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.1.4 BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020))
  10.1.5 BioReliance Recent Development
10.2 Cobra Biologics
  10.2.1 Cobra Biologics Company Details
  10.2.2 Cobra Biologics Business Overview and Its Total Revenue
  10.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.2.4 Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.2.5 Cobra Biologics Recent Development
10.3 Oxford BioMedica
  10.3.1 Oxford BioMedica Company Details
  10.3.2 Oxford BioMedica Business Overview and Its Total Revenue
  10.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.3.4 Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.3.5 Oxford BioMedica Recent Development
10.4 UniQure
  10.4.1 UniQure Company Details
  10.4.2 UniQure Business Overview and Its Total Revenue
  10.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.4.4 UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.4.5 UniQure Recent Development
10.5 FinVector
  10.5.1 FinVector Company Details
  10.5.2 FinVector Business Overview and Its Total Revenue
  10.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.5.4 FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.5.5 FinVector Recent Development
10.6 MolMed
  10.6.1 MolMed Company Details
  10.6.2 MolMed Business Overview and Its Total Revenue
  10.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.6.4 MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.6.5 MolMed Recent Development
10.7 MassBiologics
  10.7.1 MassBiologics Company Details
  10.7.2 MassBiologics Business Overview and Its Total Revenue
  10.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.7.4 MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.7.5 MassBiologics Recent Development
10.8 Richter-Helm
  10.8.1 Richter-Helm Company Details
  10.8.2 Richter-Helm Business Overview and Its Total Revenue
  10.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.8.4 Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.8.5 Richter-Helm Recent Development
10.9 FUJIFILM Diosynth Biotechnologies
  10.9.1 FUJIFILM Diosynth Biotechnologies Company Details
  10.9.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
  10.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
10.10 Lonza
  10.10.1 Lonza Company Details
  10.10.2 Lonza Business Overview and Its Total Revenue
  10.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.10.4 Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.10.5 Lonza Recent Development
10.11 Aldevron
  10.11.1 Aldevron Company Details
  10.11.2 Aldevron Business Overview and Its Total Revenue
  10.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.11.4 Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.11.5 Aldevron Recent Development
10.12 Eurogentec
  10.12.1 Eurogentec Company Details
  10.12.2 Eurogentec Business Overview and Its Total Revenue
  10.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.12.4 Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.12.5 Eurogentec Recent Development
10.13 Cell and Gene Therapy Catapult
  10.13.1 Cell and Gene Therapy Catapult Company Details
  10.13.2 Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
  10.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.13.5 Cell and Gene Therapy Catapult Recent Development
10.14 Biovian
  10.14.1 Biovian Company Details
  10.14.2 Biovian Business Overview and Its Total Revenue
  10.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.14.4 Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.14.5 Biovian Recent Development
10.15 Brammer Bio
  10.15.1 Brammer Bio Company Details
  10.15.2 Brammer Bio Business Overview and Its Total Revenue
  10.15.3 Brammer Bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.15.4 Brammer Bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.15.5 Brammer Bio Recent Development
10.16 VGXI
  10.16.1 VGXI Company Details
  10.16.2 VGXI Business Overview and Its Total Revenue
  10.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.16.4 VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.16.5 VGXI Recent Development
10.17 PlasmidFactory
  10.17.1 PlasmidFactory Company Details
  10.17.2 PlasmidFactory Business Overview and Its Total Revenue
  10.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.17.4 PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.17.5 PlasmidFactory Recent Development
10.18 bluebird bio
  10.18.1 bluebird bio Company Details
  10.18.2 bluebird bio Business Overview and Its Total Revenue
  10.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.18.4 bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.18.5 bluebird bio Recent Development
10.19 Novasep
  10.19.1 Novasep Company Details
  10.19.2 Novasep Business Overview and Its Total Revenue
  10.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.19.4 Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.19.5 Novasep Recent Development
10.20 Spark Therapeutics
  10.20.1 Spark Therapeutics Company Details
  10.20.2 Spark Therapeutics Business Overview and Its Total Revenue
  10.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.20.4 Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.20.5 Spark Therapeutics Recent Development
10.21 Vigene Biosciences
  10.21.1 Vigene Biosciences Company Details
  10.21.2 Vigene Biosciences Business Overview and Its Total Revenue
  10.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Introduction
  10.21.4 Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
  10.21.5 Vigene Biosciences Recent Development

11ANALYST'S VIEWPOINTS/CONCLUSIONS

12APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of AAV
Table 6. Key Players of Adenoviral
Table 7. Key Players of Lentiviral
Table 8. Key Players of Retroviral
Table 9. Key Players of Plasmid DNA
Table 10. Key Players of Other Vectors
Table 11. COVID-19 Impact Global Market: (Four Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players to Combat Covid-19 Impact
Table 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2015-2020)
Table 20. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Strategy
Table 26. Main Points Interviewed from Key Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players
Table 27. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 28. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players (2015-2020)
Table 29. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2019)
Table 30. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service
Table 33. Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 36. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Type (2015-2020)
Table 37. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2021-2026)
Table 38. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Application (2015-2020)
Table 39. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 40. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Share by Application (2021-2026)
Table 41. North America Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share (2019-2020)
Table 43. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 44. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2015-2020)
Table 45. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 46. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2015-2020)
Table 47. Europe Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share (2019-2020)
Table 49. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2015-2020)
Table 51. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2015-2020)
Table 53. China Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2019-2020) (Million US$)
Table 54. China Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share (2019-2020)
Table 55. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 56. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2015-2020)
Table 57. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 58. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2015-2020)
Table 59. Japan Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share (2019-2020)
Table 61. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type (2015-2020)
Table 63. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application (2015-2020)
Table 65. BioReliance Company Details
Table 66. BioReliance Business Overview
Table 67. BioReliance Product
Table 68. BioReliance Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 69. BioReliance Recent Development
Table 70. Cobra Biologics Company Details
Table 71. Cobra Biologics Business Overview
Table 72. Cobra Biologics Product
Table 73. Cobra Biologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 74. Cobra Biologics Recent Development
Table 75. Oxford BioMedica Company Details
Table 76. Oxford BioMedica Business Overview
Table 77. Oxford BioMedica Product
Table 78. Oxford BioMedica Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 79. Oxford BioMedica Recent Development
Table 80. UniQure Company Details
Table 81. UniQure Business Overview
Table 82. UniQure Product
Table 83. UniQure Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 84. UniQure Recent Development
Table 85. FinVector Company Details
Table 86. FinVector Business Overview
Table 87. FinVector Product
Table 88. FinVector Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 89. FinVector Recent Development
Table 90. MolMed Company Details
Table 91. MolMed Business Overview
Table 92. MolMed Product
Table 93. MolMed Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 94. MolMed Recent Development
Table 95. MassBiologics Company Details
Table 96. MassBiologics Business Overview
Table 97. MassBiologics Product
Table 98. MassBiologics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 99. MassBiologics Recent Development
Table 100. Richter-Helm Business Overview
Table 101. Richter-Helm Product
Table 102. Richter-Helm Company Details
Table 103. Richter-Helm Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 104. Richter-Helm Recent Development
Table 105. FUJIFILM Diosynth Biotechnologies Company Details
Table 106. FUJIFILM Diosynth Biotechnologies Business Overview
Table 107. FUJIFILM Diosynth Biotechnologies Product
Table 108. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 109. FUJIFILM Diosynth Biotechnologies Recent Development
Table 110. Lonza Company Details
Table 111. Lonza Business Overview
Table 112. Lonza Product
Table 113. Lonza Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 114. Lonza Recent Development
Table 115. Aldevron Company Details
Table 116. Aldevron Business Overview
Table 117. Aldevron Product
Table 118. Aldevron Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 119. Aldevron Recent Development
Table 120. Eurogentec Company Details
Table 121. Eurogentec Business Overview
Table 122. Eurogentec Product
Table 123. Eurogentec Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 124. Eurogentec Recent Development
Table 125. Cell and Gene Therapy Catapult Company Details
Table 126. Cell and Gene Therapy Catapult Business Overview
Table 127. Cell and Gene Therapy Catapult Product
Table 128. Cell and Gene Therapy Catapult Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 129. Cell and Gene Therapy Catapult Recent Development
Table 130. Biovian Company Details
Table 131. Biovian Business Overview
Table 132. Biovian Product
Table 133. Biovian Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 134. Biovian Recent Development
Table 135. Brammer Bio Company Details
Table 136. Brammer Bio Business Overview
Table 137. Brammer Bio Product
Table 138. Brammer Bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 139. Brammer Bio Recent Development
Table 140. VGXI Company Details
Table 141. VGXI Business Overview
Table 142. VGXI Product
Table 143. VGXI Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 144. VGXI Recent Development
Table 145. PlasmidFactory Company Details
Table 146. PlasmidFactory Business Overview
Table 147. PlasmidFactory Product
Table 148. PlasmidFactory Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 149. PlasmidFactory Recent Development
Table 150. bluebird bio Company Details
Table 151. bluebird bio Business Overview
Table 152. bluebird bio Product
Table 153. bluebird bio Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 154. bluebird bio Recent Development
Table 155. Novasep Company Details
Table 156. Novasep Business Overview
Table 157. Novasep Product
Table 158. Novasep Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 159. Novasep Recent Development
Table 160. Spark Therapeutics Company Details
Table 161. Spark Therapeutics Business Overview
Table 162. Spark Therapeutics Product
Table 163. Spark Therapeutics Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 164. Spark Therapeutics Recent Development
Table 165. Vigene Biosciences Company Details
Table 166. Vigene Biosciences Business Overview
Table 167. Vigene Biosciences Product
Table 168. Vigene Biosciences Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020) (Million US$)
Table 169. Vigene Biosciences Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. AAV Features
Figure 3. Adenoviral Features
Figure 4. Lentiviral Features
Figure 5. Retroviral Features
Figure 6. Plasmid DNA Features
Figure 7. Other Vectors Features
Figure 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Application: 2020 VS 2026
Figure 9. Cancers Case Studies
Figure 10. Inherited Disorders Case Studies
Figure 11. Viral Infections Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Report Years Considered
Figure 14. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions: 2020 VS 2026
Figure 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players in 2019
Figure 19. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2019
Figure 21. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. BioReliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BioReliance Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 27. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Cobra Biologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 29. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Oxford BioMedica Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 31. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. UniQure Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 33. FinVector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. FinVector Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 35. MolMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MolMed Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 37. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. MassBiologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 39. Richter-Helm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Richter-Helm Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 41. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 43. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Lonza Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 45. Aldevron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Aldevron Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 47. Eurogentec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Eurogentec Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 49. Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 51. Biovian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Biovian Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 53. Brammer Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Brammer Bio Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 55. VGXI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. VGXI Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 57. PlasmidFactory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. PlasmidFactory Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 59. bluebird bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. bluebird bio Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 61. Novasep Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Novasep Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 63. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Spark Therapeutics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed